• Personalized Oncology Therapies Require Personalized Oncology Patient-Reported Outcome Measures

    Feb 5, 2018, 15:32 PM
  • By the Numbers

    Feb 5, 2018, 15:30 PM
  • Assessing the Value of Cancer Immunotherapies

    Feb 5, 2018, 15:30 PM
  • From the Journals

    Feb 5, 2018, 15:29 PM
  • Research Roundup

    Feb 5, 2018, 15:28 PM
  • Conferences & Events

    Feb 5, 2018, 15:28 PM
  • HEOR News

    Feb 5, 2018, 15:27 PM
  • ISPOR Speaks – A Look Ahead: ISPOR’s Role in Shaping the Future of HEOR

    Feb 5, 2018, 15:26 PM
  • New Year, New Look...

    Feb 5, 2018, 15:25 PM
  • The Good, the Bad, and the Ugly: Reminders About Propensity Scores

    Dec 11, 2017, 16:12 PM
  • ISPOR Value in Health Regional Issues Volume 14 Highlights

    Dec 5, 2017, 16:41 PM
  • Value in Health Most Cited Articles 2017

    Dec 5, 2017, 16:41 PM
  • Trends in Student Interests from 2011-2016: A Report from the ISPOR Survey and Evaluation Committee

    Dec 5, 2017, 16:40 PM
  • Value in Health Volume 20, Issue 10 Highlights

    Dec 5, 2017, 16:40 PM
  • Real-World Evidence in Health Care Decision Making Summit: Recommendations from the Joint ISPOR-ISPE Special Task Force

    Dec 5, 2017, 16:36 PM
  • ISPOR 20th Annual European Congress Photo Gallery

    Dec 5, 2017, 16:34 PM
  • ISPOR Scientific Achievement Awards

    Dec 5, 2017, 16:34 PM
  • ISPOR 20th Annual European Congress Highlights At-A-Glance

    Dec 5, 2017, 16:33 PM
  • Measuring Multiple Medication Adherence–Which Measure When?

    Dec 5, 2017, 16:07 PM
  • The Increasing Role of Qualitative Evidence on Health Preferences for Regulatory Decision Making

    Dec 5, 2017, 15:55 PM
  • Differential Pricing of Medicines in Europe: Implications for Access, Innovation, and Affordability

    Dec 5, 2017, 15:55 PM
  • The Complexities of Medicare Directly Negotiating Drug Prices

    Dec 5, 2017, 15:51 PM
  • A Call for Women in HEOR

    Dec 5, 2017, 15:50 PM
  • The Complexities of Prescription Drug Pricing Around the World

    Dec 5, 2017, 15:49 PM
  • São Paulo Highlights at a Glance

    Oct 6, 2017, 10:06 AM
  • ISPOR Value in Health Regional Issues Excellent Article Award 2017

    Oct 6, 2017, 10:06 AM
  • Value in Health Volume 20, Issue 8 Highlights

    Oct 6, 2017, 10:05 AM
  • Value in Health Regional Issues Volume 13 Highlights

    Oct 6, 2017, 10:05 AM
  • Trends in Student Interests from 2011-2016: A Report from the ISPOR Survey and Evaluation Committee

    Oct 6, 2017, 10:04 AM
  • Compassionate, Humanistic Leadership: A Profile of C. Daniel Mullins, PhD

    Oct 6, 2017, 10:03 AM
  • A Highlight of Similarities and Differences Between the HTA Core Model 3.0 and the AMCP Format 4.0

    Oct 6, 2017, 10:02 AM
  • The Current Biosimilars Landscape and Methodological Considerations for Real-World Evidence Generation

    Oct 6, 2017, 09:45 AM
  • Maximizing the Utility of Real-World Evidence: Integration of Structured Electronic Medical Record (EMR) Data, Unstructured EMR Data, and Billing Data for Economics and Outcomes Research in Oncology

    Oct 5, 2017, 17:23 PM
  • Managing the Winds of Change in Real-World Evidence Studies

    Oct 5, 2017, 17:00 PM
  • Next-Generation ISPOR – Shaping the Future of HEOR

    Oct 5, 2017, 16:59 PM
  • Winds of Change Blowing Strong in RWE

    Oct 5, 2017, 16:58 PM
  • Open Access Publication in Value in Health

    Aug 24, 2017, 10:36 AM
  • Guidance for Using Outcomes Research in Clinical Trials for Rare Diseases: Summary of New ISPOR Task Force Report

    Aug 23, 2017, 10:33 AM
  • 21st Century Cures in the Global Context

    Aug 23, 2017, 10:22 AM
  • Lifetime of Achievement: A Profile of Paul Kind

    Aug 22, 2017, 10:35 AM
  • ISPOR in Transformation: The Wheels of Change Keep Turning

    Aug 18, 2017, 10:23 AM
  • Roundtable Discussions: A Framework for Efficient Transfer of Expert Opinions

    Aug 17, 2017, 10:35 AM
  • Board of Directors Newly Elected Members Take Office

    Aug 17, 2017, 10:34 AM
  • Engaging Students and Developing Leaders

    Aug 11, 2017, 10:34 AM
  • Learning by Listening, Digitally

    Aug 11, 2017, 10:30 AM
  • GetReal: Real-World Evidence Navigator: Beyond the Hype

    Aug 11, 2017, 10:27 AM
  • Accelerating Cures: Debating Speed vs. Safety

    Aug 11, 2017, 10:23 AM
  • Emerging Concepts of Value in Health Care Decision Making: The Evolution of Value in Health Care

    Aug 10, 2017, 10:36 AM
  • Q & A with Katy Benjamin and Margaret K. Vernon

    Aug 10, 2017, 10:33 AM
  • Thoughts on the Real-World Evidence Navigator

    Aug 4, 2017, 10:25 AM
  • Uniting the Global HEOR Community

    Jun 21, 2017, 10:45 AM
  • Connect. Collaborate. Cultivate: Student Activities at the ISPOR 22nd Annual International Meeting

    Jun 19, 2017, 10:58 AM
  • Value in Health Paper of the Year Award 2017

    Jun 17, 2017, 10:57 AM
  • A Focus on Regulatory Policy

    Jun 14, 2017, 10:44 AM
  • São Paulo: Bringing All Stakeholders into the Discussion for Better Decision Making in Health Care

    Jun 13, 2017, 11:00 AM
  • Summary at a Glance

    Jun 12, 2017, 10:56 AM
  • Photo Gallery

    Jun 12, 2017, 10:56 AM
  • Comparative-Effectiveness Research: New Progress in Assessing the Evidence in Today’s Health Care Marketplace

    Jun 12, 2017, 10:55 AM
  • An Introduction to Risk Adjustment in Outcomes Research Comparison of the Strength of Associations between Variants of the Charlson Comorbidity Index and Patient-Reported Health Outcomes

    Jun 12, 2017, 10:52 AM
  • Assessing the Value of Medical Devices—Choosing the Best Path Forward: Where Do We Go From Here?

    Jun 12, 2017, 10:49 AM
  • Value in Health Regional Issues Excellent Article Award 2017

    Jun 6, 2017, 10:58 AM
  • A Summary of Constrained Optimization Methods in Health Services Research—An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force

    Jun 5, 2017, 11:00 AM
  • Value in Health Volume 20, Issues 6 & 7 Highlights

    Jun 5, 2017, 10:58 AM
  • Patient Access in the Context of Adaptive Pathways for Medicines: What Could Make It Work?

    Jun 5, 2017, 10:47 AM
  • Twenty Years Not Too Late: FDA Issues Guidance to Help PhRMA Talk Health Care Economic Information with Payers

    Jun 5, 2017, 10:45 AM
  • Value in Health Regional Issues Volume 12 Highlights

    Jun 4, 2017, 10:59 AM
  • Uniting the Global HEOR Community

    Apr 25, 2017, 11:07 AM
  • What Are Students Presenting at ISPOR Conferences?

    Apr 19, 2017, 11:20 AM
  • Value in Health Volume 20, Issues 3 & 4 Highlights

    Apr 17, 2017, 11:20 AM
  • Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force

    Apr 12, 2017, 11:19 AM
  • Constrained Optimization Methods in Health Services Research: An Interview with William Crown, PhD and Kal Pasupathy PhD

    Apr 10, 2017, 11:18 AM
  • An Introduction to Competing Risks

    Apr 6, 2017, 11:16 AM
  • A Comparison of the Strength of Associations Between Variants of the Charlson Comorbidity Index and Patient-Reported Health Outcomes

    Apr 6, 2017, 11:14 AM
  • To Seek or Not to Seek Parallel European Medicine Agency and Health Technology Assessment Scientific Advice?

    Apr 6, 2017, 11:11 AM
  • Payers’ Use of Independent Reports in Decision Making – Will There Be an ICER Effect?

    Apr 6, 2017, 11:07 AM
  • It’s a Topsy-Turvy World . . .

    Apr 6, 2017, 11:06 AM
  • Evidence and Value in a Time of Social and Policy Change

    Feb 6, 2017, 12:36 PM
  • Student Network: A Year in Review

    Feb 6, 2017, 12:35 PM
  • ISPOR Task Force Report: Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures

    Feb 6, 2017, 12:34 PM
  • Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force

    Feb 6, 2017, 12:33 PM
  • Q & A with Allan Wailoo

    Feb 6, 2017, 12:33 PM
  • Q & A with John Powers

    Feb 6, 2017, 12:32 PM
  • Regenerative Therapies: Are We Ready for a Cure? Key Value and Policy Considerations to Facilitate Access

    Feb 6, 2017, 12:31 PM
  • Patient-Centeredness in Clinical Outcomes Assessment

    Feb 6, 2017, 12:26 PM
  • The Benefits of Early Engagement with Patient-Reported Outcomes Strategies in Clinical Product Development

    Feb 6, 2017, 12:23 PM
  • Visualizing Data for Hypothesis Generation Using Large-Volume Claims Data

    Feb 6, 2017, 12:18 PM
  • Conceptual Overview of Computerized Adaptive Testing

    Feb 6, 2017, 12:18 PM
  • Review and Improve: Essential Elements of ISPOR’s Continued Growth and Impact on Health Science Policy

    Feb 6, 2017, 12:17 PM
  • Can Algorithms Take Us to HEOR’s Holy Grail?

    Feb 6, 2017, 12:16 PM
  • Highlights from Value in Health

    Feb 6, 2017, 00:00 AM
  • ISPOR Marilyn Dix Smith Leadership Award Presentation and Recipient Remarks from J. Jaime Caro, MDCM, FRCPC

    Dec 6, 2016, 13:11 PM
  • 19th Annual European Congress: Vienna, Austria

    Dec 6, 2016, 13:10 PM
  • The ISPOR Institutional Council, November 2016

    Dec 6, 2016, 13:09 PM
  • Creating New Values for Students’ Professional Development: Experience from ISPOR 19th European Congress

    Dec 6, 2016, 13:08 PM
  • Value in Health’s Top Cited Papers from 2015: A Year in Review

    Dec 6, 2016, 13:06 PM
  • A Primer on Latent Class Analysis

    Dec 6, 2016, 13:04 PM
  • Perception of Anti-TNF Biosimilars among Payer Stakeholders in the United Kingdom, France, Germany, Italy, and Spain

    Dec 6, 2016, 13:00 PM
  • Performance-Based Managed Entry Agreements for Medicines: Much Needed, but Not Feasible?

    Dec 6, 2016, 12:59 PM
  • Irrationality in Health Care

    Dec 6, 2016, 12:47 PM
  • Behavioral Economics and Shifting Behavior of Patients Towards Better Health

    Dec 6, 2016, 12:46 PM
  • Global Collaboration: A Public Good and A Force for Good

    Dec 6, 2016, 12:45 PM
  • Making Medical Decisions in an Irrational World

    Dec 6, 2016, 12:44 PM
  • Highlights from the ISPOR 7th Asia-Pacific Conference

    Oct 6, 2016, 13:36 PM
  • ISPOR Awards: Call for Nominations

    Oct 6, 2016, 13:36 PM
  • ISPOR Task Force Report: Estimating Health-State Utility for Economic Models in Clinical Studies

    Oct 6, 2016, 13:35 PM
  • Student Activities at ISPOR Conferences: Sharing Experiences and New Opportunities

    Oct 6, 2016, 13:35 PM
  • How Can We Enhance the Practical Application of Outcomes Research?

    Oct 6, 2016, 13:32 PM
  • A Roadmap for Sustainable Health Care: Avoiding the ‘Perfect Storm’

    Oct 6, 2016, 13:30 PM
  • Techniques for Revalidating the Reliability and Validity of Patient-Reported Outcome Measures

    Oct 6, 2016, 13:29 PM
  • Patient Engagement in Health Outcomes Research: A Snapshot from the ISPOR Community

    Oct 6, 2016, 13:23 PM
  • Multivariate Meta-Analysis: Concepts and Applications

    Oct 6, 2016, 13:20 PM
  • What Is the Value of Big Data in Comparative-Effectiveness Research and Clinical Decision Making?

    Oct 6, 2016, 13:19 PM
  • Global Presence and Global Influence: ISPOR on the World Stage

    Oct 6, 2016, 13:18 PM
  • Framing Out Value Assessment Frameworks

    Oct 6, 2016, 13:17 PM
  • Task Force Recommendations on the Collection of Health-State Utility Data in Clinical Studies: An Interview with Sorrel E. Wolowacz, PhD

    Oct 6, 2016, 00:00 AM
  • ISPOR Value in Health Regional Issues (Asia) Excellent Article Award 2016

    Aug 6, 2016, 14:35 PM
  • ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award Presentation and Recipient Remarks: Donald Patrick and Pennifer Erickson

    Aug 6, 2016, 14:34 PM
  • Board of Directors Newly Elected Members Take Office as of July 1, 2016

    Aug 6, 2016, 14:31 PM
  • Improving the Scope of Decision Making: The ISPOR 19th Annual European Congress

    Aug 6, 2016, 14:30 PM
  • Welcome Note from the ISPOR Student Network Advisor and Network Chairs, 2016-2017

    Aug 6, 2016, 14:29 PM
  • ISPOR Task Force Report: Statistical Methods for the Analysis of Discrete-Choice Experiments

    Aug 6, 2016, 14:28 PM
  • Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group

    Aug 6, 2016, 14:27 PM
  • Health Technology Assessment for Molecular Diagnostics: An Interview with Susan Garfield, DrPh

    Aug 6, 2016, 14:27 PM
  • How Can Payer Requirements Be Satisfied when Treatment Switching Occurs?

    Aug 6, 2016, 14:25 PM
  • Medical Devices Assessment in Europe: Where Do We Stand? Inspired by Perspectives from England and Germany

    Aug 6, 2016, 14:23 PM
  • The Evaluation of Ultra-Innovative Drugs: A Broader Perspective

    Aug 6, 2016, 14:20 PM
  • Moving the ISPOR Vision and Mission Forward

    Aug 6, 2016, 14:18 PM
  • Special Cases in HTA is Our Theme

    Aug 6, 2016, 14:17 PM
  • Value in Health Information

    Aug 6, 2016, 00:00 AM
  • How Do We Evaluate Technologies That Are Not Cost Effective at Zero Price?

    Aug 6, 2016, 00:00 AM
  • The ISPOR Institutional Council

    Aug 5, 2016, 14:31 PM
  • Value in Health Regional Issues Information

    Jun 6, 2016, 15:19 PM
  • ISPOR Value in Health Regional Issues Excellent Article Award for 2016

    Jun 6, 2016, 15:18 PM
  • Value in Health Information

    Jun 6, 2016, 15:18 PM
  • ISPOR 21st Annual International Meeting Awards Recipients

    Jun 6, 2016, 15:17 PM
  • ISPOR Value in Health Paper of the Year Award 2016

    Jun 6, 2016, 15:17 PM
  • Stress, Coping, and Health-Related Quality of Life among Members in the ISPOR Student Network

    Jun 6, 2016, 15:16 PM
  • ISPOR 19th Annual European Congress Information

    Jun 6, 2016, 15:15 PM
  • ISPOR 7th Asia-Pacific Conference Program

    Jun 6, 2016, 15:15 PM
  • An Experiential Journey of Academic and Cultural Immersion in Singapore–the Lion City of Asia

    Jun 6, 2016, 15:15 PM
  • ISPOR 21st Annual International Meeting Highlights at a Glance

    Jun 6, 2016, 15:13 PM
  • ISPOR Task Force Report: Statistical Methods for the Analysis of Discrete-Choice Experiments

    Jun 6, 2016, 15:12 PM
  • Highlights of the ISPOR 21st Annual International Meeting

    Jun 6, 2016, 15:12 PM
  • Statistical Methods for the Analysis of Discrete-Choice Experiments: An Interview with A. Brett Hauber, PhD

    Jun 6, 2016, 15:11 PM
  • Interview with new ISPOR Chief Science Officer: Richard Willke, PhD

    Jun 6, 2016, 15:10 PM
  • An Introduction to Unit-of-Analysis Error

    Jun 6, 2016, 15:05 PM
  • Evidence Development and Decision Making for Medical Devices

    Jun 6, 2016, 15:04 PM
  • The Current and Future Lifecycle Approach to Decision Making on Health Technologies

    Jun 6, 2016, 15:02 PM
  • A Life-Span Approach to Decision Making: Why EU Collaboration Is a Sine Qua Non

    Jun 6, 2016, 15:00 PM
  • From Proof of Concept to Basis for Initial Marketing Authorization, HTA Appraisal and Reimbursement: Clinical Phase II in the Context of Adaptive Pathways

    Jun 6, 2016, 14:59 PM
  • Fulfilling our Mission

    Jun 6, 2016, 14:58 PM
  • The Greatest of All Time

    Jun 6, 2016, 14:56 PM
  • Student Network Chapter Event Highlights

    Apr 6, 2016, 15:38 PM
  • Upcoming ISPOR Meetings

    Apr 6, 2016, 15:38 PM
  • Value in Health Information

    Apr 6, 2016, 15:37 PM
  • Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force

    Apr 6, 2016, 15:37 PM
  • ISPOR Board of Directors Election – Candidate Information

    Apr 6, 2016, 15:37 PM
  • Highlights from ISPOR’s Value & Outcomes Spotlight Member Survey

    Apr 6, 2016, 15:37 PM
  • How an Early Network Meta-Analysis Can Inform Clinical Trial Design and Help with Health Technology Assessment Submissions

    Feb 17, 2016, 16:09 PM
  • ISPOR 21st Annual International Meeting Program

    Feb 17, 2016, 16:09 PM
  • Your Invitation to ISPOR’s 21st Annual International Meeting to Engage in 21st Century Health Care Solutions

    Feb 17, 2016, 16:09 PM
  • The Nordic Health Care Registries–Real Improvement to Outcomes Research?

    Feb 17, 2016, 16:09 PM
  • Instrumental Variables: A Tool to Reduce Bias in Non-Randomized Studies

    Feb 17, 2016, 16:09 PM
  • Spotlight on Europe . . .

    Feb 17, 2016, 16:09 PM
  • Are We Moving Towards Collaborative European Rapid Relative Effectiveness Assessments? Insights Gleaned from the EUnetHTA Joint Assessment of Canagliflozin–Approaching Joint Relative Effectiveness Assessments

    Feb 17, 2016, 16:09 PM
  • Implementing a New Strategic Plan

    Feb 17, 2016, 16:09 PM
  • Student Network Chapter Event Highlights

    Feb 17, 2016, 16:09 PM
  • Multiple Criteria Decision Analysis for Health Care Decision Making An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force

    Feb 17, 2016, 16:09 PM
  • Novel Methods for Indirect Comparison of Treatments: When Are They Needed and How Do They Work?

    Feb 17, 2016, 16:09 PM
  • ISPOR Upcoming Meetings

    Feb 17, 2016, 16:09 PM
  • Value in Health Information

    Feb 17, 2016, 16:09 PM
  • Patient Registries as Instruments for HTA Outcomes Research: A European Perspective

    Feb 17, 2016, 16:09 PM
  • ISPOR 19th Annual European Congress Call for Abstracts

    Feb 17, 2016, 16:09 PM
  • ISPOR 7th Asia-Pacific Conference Call for Abstracts

    Feb 17, 2016, 16:09 PM
  • Multiple Criteria Decision Analysis for Health Care Decision Making–An Interview with Praveen Thokala, PhD

    Feb 17, 2016, 16:09 PM
  • Health Care Transformation and the Learning Health System: Where Are We and What’s Next?

    Dec 17, 2015, 16:35 PM
  • Assessing the Impact of Morbidity in Populations of North London Clinical Commissioning Groups on Patient Admission Rates

    Dec 17, 2015, 16:35 PM
  • How Should We Value Disease Eradication?

    Dec 17, 2015, 16:35 PM
  • Highlights of the ISPOR 18th Annual European Congress

    Dec 17, 2015, 16:35 PM
  • Learning About the Learning Health Care System . . .

    Dec 17, 2015, 16:35 PM
  • The Learning Health System: An Optimist’s Perspective

    Dec 17, 2015, 16:35 PM
  • Toward a True Rapid Learning Health Care System: How Can We Build Both the Will and the Skill?

    Dec 17, 2015, 16:35 PM
  • 2015 Exhibitors and Sponsors Thank You

    Dec 17, 2015, 16:35 PM
  • Fulfilling Our Mission

    Dec 17, 2015, 16:35 PM
  • ISPOR 18th Annual European Congress Highlights at a Glance

    Dec 17, 2015, 16:35 PM
  • Value in Health and Value in Health Regional Issues Information

    Dec 16, 2015, 16:38 PM
  • ISPOR 21st Annual Meeting Call for Abstracts

    Dec 16, 2015, 16:38 PM
  • The ISPOR Award for Excellence in Methodology in Pharmacoeconomics and Health Outcomes Research – Q & A with 2015 Recipient Lisa Prosser, PhD

    Dec 16, 2015, 16:38 PM
  • Promoting Health Services Research across Disciplines: Role of Interprofessional Education

    Dec 16, 2015, 16:38 PM
  • Standing on the Shoulders of Giants – ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award Presentation and Recipient Remarks: Adrian Towse and Anthony J. Culyer

    Dec 16, 2015, 16:38 PM
  • ISPOR Upcoming Meetings

    Dec 16, 2015, 16:38 PM
  • ISPOR 7th Asia-Pacific Conference Call for Abstracts

    Dec 16, 2015, 16:38 PM
  • Veni, vidi, vici! Student Activities at the ISPOR 18th Annual European Congress

    Dec 16, 2015, 16:38 PM
  • Positioning ISPOR to Promote Health Economics and Outcomes Research Excellence

    Oct 20, 2015, 16:57 PM
  • ISPOR 7th Asia-Pacific Conference Call for Abstracts

    Oct 20, 2015, 16:57 PM
  • Highlights of the ISPOR 5th Latin America Conference

    Oct 20, 2015, 16:57 PM
  • Real-world data... and so much more

    Oct 20, 2015, 16:57 PM
  • Rare Diseases Terminology & Definitions – An Interview with Trevor Richter, PhD, MS

    Oct 20, 2015, 16:57 PM
  • Welcome Note from ISPOR Student Network Advisory and Past and Present Chairs

    Oct 20, 2015, 16:57 PM
  • Principles of Highly Effective Outcomes Research Consulting Teams

    Oct 20, 2015, 16:57 PM
  • 1
  • 2 (current)
  • 3